Imaging of δ opioid receptors in human brain by N1'- ([11C]methyl)naltrindole and PET

Synapse

Volumn 24, Issue 1, 1996, Pages 19-28

  Madar, Igal ^a   Lever, John R ^a   Kinter, Chris M ^a   Scheffel, Ursula ^a   Ravert, Hayden T ^a   Musachio, John L ^a   Mathews, William B ^a   Dannals, Robert F ^a   Frost, J James ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delta opioid receptors; Human brain; Methylnaltrindole; Positron emission tomography

Indexed keywords

DELTA OPIATE RECEPTOR; NALTRINDOLE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MOUSE; NEOCORTEX; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOMETRY; RECEPTOR BINDING; RECEPTOR POTENTIAL; RESPIRATION DEPRESSION; SEDATION;

ADULT; BRAIN; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NALTREXONE; RECEPTORS, OPIOID, DELTA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029789198     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199609)24:1<19::AID-SYN3>3.0.CO;2-J     Document Type: Article

References (45)

1. Abdelhamid, E.E., Sultana, M., Portoghese, P.S., Takemori, A.E. (1991) Selective blockage of deltaopioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258:299-303.
2. Charness, M.E., Hu, G., Edwards, R.H., and Querimit, L.A. (1993) Ethanol increases 8-opiod receptor expression in neuronal cell lines. Soc. Neurosci. Abstr., 19:845.
3. Chung, H.D., Barg, J., Belchyia, M.M., Rowinski, J., Ho, A., Burke, W.J., Schmidt, C.A., and Coscia, C.J. (1993) Opioid receptor density changes in Alzheimer amygdala and putamen. Soc. Neurosci. Abstr., 19:401.
4. Contreras, P.C., Tam, L., Drower, E., and Rafferty, M.F. (1993) [3H]naltrindole: A potent and selective ligand for labeling delta-opioid receptors. Brain Res., 26:160-164.
5. Delay-Goyet, P., Ruiz, G.M., Baamonde, A., Gacel, G., Morgat, J.-L., and Roques, B.P. (1991) Brain passage of BUBU, a highly selective and potent agonist for δ opioid receptors: In vivo binding and μ versus δ receptors occupancy. Pharmacol. Biochem. Behav., 38: 155-158.
6. Fox, P.T., Perlmuter, J.S., and Raichel, M.E. (1985) A stereotactic method of anatomical localization for positron emission tomography. J. Comput. Assist. Tomogr., 9:141-153.
7. Frost, J.J. (1986) Imaging neuronal biochemistry by emission computed tomography: Focus on neuroreceptors. Trends Pharmacol. Sci., 7:490-496.
8. Frost, J.J., Wagner, H.N., Jr., Dannals, R.F., Ravert, H.T., Links, J.M., Wilson, A.A., Burns, H.D., Wong, D.F., McPherson, R.W., Rosenbaum, A.E., Kuhar M.J., and Snyder, S.H. (1985) Imaging opiate receptors in the human brain by positron tomography. J. Comput. Assist. Tomogr., 9:231-236.
9. Frost, J.J., Mayberg, H.S., Fisher, R.S., Douglass, K.H., Dannals, R.F., Links, J.M., Wilson, A.A., Ravert, H.T., Rosenbaum, A.E., Snyder, S.H., and Wagner, H.N., Jr. (1988) Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann. Neurol., 23:231-237.
10. 11C]carfentanil binding to opiate receptors in humans by positron emission tomography. J. Cereb. Blood Flow Metab., 10:484-492.
11. Gilbert, P.E., and Martin, W.R. (1976) The effect of morphine- and nalorphine-like drugs in nondependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther., 198:66-82.
12. Gjedde, A., and Wong, D.F. (1990) Modeling neuroreceptor binding of radioligands in vivo. In: Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes. J.J. Frost and H.N. Wagner, Jr., eds. Raven Press, New York, pp. 51-79.
13. Hiller, J.M., Itzhak, Y., and Simon, E.J. (1987) Selective changes in mu, delta and kappa opioid binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res., 406:17-23.
14. International Commission on Radiological Protection (1990) Recommendations of the International Commission on Radiological Protection. Pergamon Press, Oxford.
15. Jain, A.K. (1989) Fundamentals of Image Processing. Prentice-Hill.
16. 11C]diprenorphine in normal volunteers. J. Neurosci. Methods, 23:121-129.
17. Koide, S., Onishi, H., Yamagami, S., and Kawakita, Y. (1992) Effects of morphine and D-Ala2-D-Leu5-enkephalin in the seizure- susceptible E1 mouse. Neurochem. Res., 17:779-783.
18. Kuhar, M.J., Pert, C.B., and Snyder, S.H. (1973) Regional distribution of opiate receptor binding in monkey and human brain. Nature, 245:447-450.
19. 11C]methyl)naltrindole to δ opioid receptors in mouse brain. Eur. J. Pharmacol., 216:459-460.
20. 11C]MeNTI]: A radioligand for positron emission tomographic studies of delta opioid receptors. J. Labelled Compds. Radiopharm., 36:137-145.
21. Loevinger, R., Budinger, T.F., and Watson, E.E. (1988) MIRD Primer for Absorbed Dose Calculations. The Society of Nuclear Medicine, New York.
22. Martin, W.R., Eades, C.G., Thompson, J.A., Huppler, R., and Gilbert, P.E. (1976) The effect of morphine- and nalorphine-like drugs in nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther., 197:517-532.
23. Mayberg, A., and Frost, J.J. (1990) Opiate receptors. In: Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes. J.J. Frost and H.N. Wagner, Jr., eds. Raven Press, New York, pp. 81-95.
24. Mayberg, H.S., Ross, C.A., Dannals, R.F., Ravert, H.T., Wagner, H.N., Jr., and Frost, J.J. (1991a) Elevated mu opiate receptors measured by PET in patients with depression. J. Cereb. Blood Flow Metab. 11(Suppl):S821.
25. Mayberg, H.S., Sadzot, B., Meltzer, C.C., Fisher, R.S., Lesser, R.P., Dannals, R.F., Lever, J.R., Wilson, A.A., Ravert, H.T., Wagner, H.N., Jr., Brian, R.N., Cromwell, C.C., and Frost, J.J. (1991b) Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann. Neurol., 30:3-11.
26. Meltzer, C.C., Bryan, R.N., Holcomb, H.H., Kimball, A.W., Mayberg, H.S., Sadzot, B., Leal, J.P., Wagner, H.N., Jr., and Frost, J.J. (1990) Anatomical localization for PET using MR imaging. J. Comput, Assist. Tomogr., 14:418-426.
27. Menkens, K., Bilsky, E.J., Wild, K.O., Portoghese, P.S., Reid, L.D., Porreca, F. (1992) Cocaine place preference is blocked by the delta-opioid receptor antagonist naltrindole. Eur. J. Pharmacol. 219:345-346.
28. Miyamoto, Y., Portoghese, P.S., and Takemori, A.E. (1993) Involvement of delta 2 opioid receptors in the development of morphine dependence in mice. J. Pharmacol. Exp. Ther., 264:1141-1145.
29. Muller-Gartner, H.W., Mayberg, H.S., Tune, L., Brandt, J., Dannals, R.F., Wilson, A.A., Ravert, H.T., and Frost, J.J. (1991) Reduced mu opiate receptors binding in the amygdala in Alzheimer's disease as assessed in vivo by C-11 carfentanil and PET. J. Nucl. Med., 32: 1079.
30. Negus, S.S., Henriksen, S.J., Mattox, A., Pasternak, G.W., Portoghese, P.S., Takemori, A.E., Weinger, M.B., and Koob, G.F. (1993) Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther., 265:1245-1252.
31. Onishi, H., Koide, S., Yamagami, S., and Kawakita, Y. (1990) Developmental and regional alteration of methionine enkephalin-like immunoreactivity in seizure-susceptible E1 mouse brain. Neurochem. Res., 15:83-87.
32. Pert, C.B., Danks, J.A., Channing, M.A., Eckelman, W.C., Larson, S.M., Bennett, J.M., Burke, T.R., Jr., and Rice, K.C. (1984)3-[18F]acetylcyclofoxy: A useful probe for the visualization of opiate receptors in living animals. FEBS Lett., 177:281-286.
33. Pfeiffer, A., Pasi, A., Mehraein, P., and Herz, A. (1982) Opiate receptor binding in human brain. Brain Res., 248:87-96.
34. Portoghese, P.S., Sultana, M., and Takemori, A.E. (1988) Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur. J. Pharmacol., 146:185-186.
35. Portoghese, P.S., Sultana, M., and Takemori, A.E. (1990) Design of peptidomimetic δ opioid receptor antagonists using the message-address concept. J. Med. Chem., 33:1714-1720.
36. Reid, L.D., Hubbell, C.L., Glaccum, M.B., Bilsky, E., Portoghese, P.S., and Porreca, F. (1992) Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding facilitation for rewarding brain stimulation. Life Sci., 52:67-71.
37. 3H]cyclofoxy: An opiate antagonist suitable for positron emission tomography. Biol. Psychiatry, 23: 435-458.
38. 11C-diprenorphine and positron emission tomography. J. Cereb. Blood Flow Metab., 11:204-219.
39. Smith, J.S., Zubieta, J.K., Price, J.C., Madar, I., Lever, J.R., Kinter, C.M., Dannals, R.F., Frost, J.J. (1994) Tracer kinetic analysis of the delta-opioid antagonist Ni-([C11]methyl)natrindole in human brain with PET. J. Nuc. Med. 35:67p.
40. 3H]carfentanil in human and rat brain. Eur. J. Pharmacol., 14:221-228.
41. Tortella, F.C. (1988) Endogenous opioid peptides and epilepsy: Quieting the seizing brain? Trends Pharmacol. Sci., 9:366-372.
42. Tortella, F.C., Robles, L., Mosberg, H.I., and Holaday, J.W. (1984) Electroencephalographic evaluation of the role of δ receptors in opiod peptide-induced seizures. Neuropeptides, 5:213-216.
43. Wong, D.F., Gjedde, A., and Wagner, H.N., Jr. (1986) Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligand. J. Cereb. Blood Flow Metab., 6:137-146.
44. 3H]naltrindole binding to delta opioid receptors in rat brain. Life Sci., 50:PL119.
45. Yurdaydin, J., Li, Y., and Basile, A.S. (1993) Brain opioid peptides are increased in an animal model of hepatic encephalopathy. Soc. Neurosci. Abstr., 19:234.